由染色体不稳定引起的非细胞自主癌症进展
在PubMed上查看摘要
概括
此摘要是机器生成的。染色体不稳定性 (CIN) 通过激活cGAS-STING通路驱动癌症转移,从而创造出转移性瘤环境. 干预这种途径可以抑制转移,特别是在免疫能力较强的环境中.
科学领域
- 癌症学
- 免疫学
- 遗传学
背景情况
- 染色体不稳定 (CIN) 是已知的癌症转移的驱动因素.
- 免疫系统在CIN驱动的转移中的作用尚未完全理解.
研究的目的
- 研究CIN诱导的cGAS-STING通路的慢性激活如何影响瘤微环境和转移.
- 在CIN驱动的癌症中探索针对cGAS-STING途径的治疗策略.
主要方法
- 使用 ContactTracing,这是一个用于分析单细胞转录组数据的细胞相互作用的新工具.
- 研究了癌细胞中CIN诱导的信号传递,包括cGAS- STING通路的激活,干扰素反应和内质网膜 (ER) 应激.
- 评估了CIN逆转,STING枯竭和ER应激抑制对免疫能力和免疫损害模型转移的影响.
- 在黑色素瘤,乳腺癌和结直肠癌的临床前模型中评估STING抑制剂.
- 分析了人类三阴性乳腺癌 (TNBC) 与CIN,cGAS激活,ER压力和转移之间的关联.
主要成果
- 由CIN诱导的cGAS-STING激活导致癌细胞的信号重新连接,从而促进瘤转移的微环境.
- 这种重新连接涉及STING下游的I型干扰素分泌和增加ER应力.
- 逆转CIN,抑制STING或阻断ER压力取消了CIN依赖的转移前效应,并抑制了免疫能力强的转移.
- 在各种类型的癌症中,STING抑制剂有效地减少了由CIN驱动的转移,这取决于瘤细胞内在的STING.
- 人类TNBC中的CIN和cGAS激活与ER压力,免疫抑制和转移相关.
结论
- cGAS-STING通路和随后的ER压力是CIN驱动转移的关键媒介.
- 针对瘤细胞内在的STING为CIN驱动的癌症提供了一个有前途的治疗策略.
- 由CIN引起的炎症和相关的ER压力是转移和免疫抑制的关键因素,特别是在TNBC中.
相关概念视频
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumors may result in a case where two people have the same mutations in an oncogene or tumor...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

